Thus, CD84 deficiency in the environment of mice injected with MM results in a significant reduction in MDSC immunosuppression, resulting in a significant increase in T cell activity, and leading to a substantial reduction in tumor load. This evidence concerns the gene CD84 and Miyoshi myopathy.